- Training
- April 2025
- 6 Hours
Europe
From €731EUR$798USD£621GBP
- Report
- May 2024
- 200 Pages
Global
From €3799EUR$4,150USD£3,229GBP
- Report
- February 2024
- 160 Pages
Global
From €4549EUR$4,969USD£3,866GBP
- Training
- December 2023
- 2 Days
Global
From €1687EUR$1,843USD£1,433GBP
- Webinar
- December 2023
- 180 Minutes
United States
From €1461EUR$1,597USD£1,242GBP
- Report
- September 2023
Global
€2243EUR$2,450USD£1,906GBP
- Training
- May 2023
- 2 Days
Global
From €1687EUR$1,843USD£1,433GBP
- Webinar
- May 2023
- 360 Minutes
Europe
From €545EUR$595USD£463GBP
- Training
- January 2022
- 2 Days
Global
From €1830EUR$1,999USD£1,555GBP
€2436EUR$2,754USD£2,000GBP
€1461EUR$1,652USD£1,200GBP
- Training
- 13 Hours
Global
€1464EUR$1,599USD£1,244GBP
- Training
- 60 Minutes
Global
- Training
- 60 Minutes
Global
- Training
- 60 Minutes
Global
- Training
- 60 Minutes
Global
- Training
- 60 Minutes
Global
- Training
- 90 Minutes
Global
- Training
- 16 Hours
Brazil
€1647EUR$1,799USD£1,400GBP
- Training
- 4 Hours
Europe

The Pharmacovigilance market is a subset of the Healthcare Services industry, focusing on the monitoring and assessment of the safety of pharmaceutical products. It involves the collection, analysis, and reporting of adverse events related to the use of drugs, as well as the identification of potential risks associated with their use. Pharmacovigilance activities are conducted by pharmaceutical companies, regulatory authorities, and healthcare professionals.
Pharmacovigilance activities are essential for the safe and effective use of drugs, as they help to identify potential risks and ensure that the benefits of the drug outweigh the risks. Pharmacovigilance also helps to ensure that the drug is used appropriately and that any adverse events are reported and addressed.
Some companies in the Pharmacovigilance market include Parexel, Quintiles, Covance, PRA Health Sciences, and ICON. Show Less Read more